Stericycle (NASDAQ:SRCL) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Stericycle (NASDAQ:SRCL) in a research report released on Saturday. The brokerage issued a hold rating on the business services provider’s stock.

Several other equities research analysts have also commented on SRCL. Robert W. Baird decreased their target price on shares of Stericycle from $62.00 to $55.00 and set a neutral rating on the stock in a research report on Friday, April 26th. Wells Fargo & Company upped their target price on shares of Stericycle from $40.00 to $48.00 and gave the company an underweight rating in a report on Friday, March 1st. Royal Bank of Canada reiterated a sector perform rating and set a $62.00 price target (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Truist Financial upped their price objective on shares of Stericycle from $50.00 to $62.00 and gave the company a hold rating in a research note on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of Stericycle from $135.00 to $142.00 and gave the stock an outperform rating in a research note on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of Hold and an average target price of $74.00.

Stericycle Trading Down 0.2 %

NASDAQ:SRCL opened at $57.95 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.55. The company has a market capitalization of $5.38 billion, a PE ratio of -263.41, a P/E/G ratio of 3.13 and a beta of 1.11. Stericycle has a 52-week low of $37.78 and a 52-week high of $59.45. The stock’s 50 day moving average price is $52.07 and its 200 day moving average price is $50.92.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, topping the consensus estimate of $0.54 by $0.03. The business had revenue of $664.90 million during the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company’s quarterly revenue was down 2.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.49 earnings per share. On average, research analysts anticipate that Stericycle will post 2.32 EPS for the current year.

Hedge Funds Weigh In On Stericycle

A number of large investors have recently bought and sold shares of the stock. Boston Partners raised its position in shares of Stericycle by 57.7% in the 1st quarter. Boston Partners now owns 15,520 shares of the business services provider’s stock worth $819,000 after buying an additional 5,681 shares during the period. Virtu Financial LLC purchased a new position in shares of Stericycle in the 1st quarter worth about $209,000. SkyView Investment Advisors LLC lifted its stake in shares of Stericycle by 11.9% in the 1st quarter. SkyView Investment Advisors LLC now owns 16,051 shares of the business services provider’s stock valued at $847,000 after purchasing an additional 1,704 shares in the last quarter. Earnest Partners LLC grew its holdings in shares of Stericycle by 12.4% during the 1st quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock worth $129,766,000 after purchasing an additional 271,025 shares during the period. Finally, Capital Research Global Investors grew its holdings in shares of Stericycle by 11.4% during the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after purchasing an additional 679,974 shares during the period. Hedge funds and other institutional investors own 98.82% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.